Rare Blood Cancer Trumps Traditional Tests in a Devout Patient

A man in his fifties arrived at the clinic with a very high white blood cell count, fever, fatigue and an enlarged liver and spleen. The first tests on his blood hinted at a type of T‑cell leukemia called prolymphocytic leukaemia. However, a deeper look into his bone marrow and detailed genetic studies revealed that he actually had anaplastic large cell lymphoma with a specific protein marker, ALK.Because he follows the Jehovah’s Witness faith and refuses blood products, doctors chose drugs that target the cancer directly and spare his immune system. The initial response to these medicines was modest, but the disease kept advancing quickly. This story shows how important it is to consider many possible diagnoses, use advanced tests wisely, and tailor treatment plans to each patient’s unique circumstances.